{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:59:23Z","timestamp":1761742763221},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T00:00:00Z","timestamp":1148342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T00:00:00Z","timestamp":1148342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1038\/sj.pcan.4500885","type":"journal-article","created":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T08:32:33Z","timestamp":1148373153000},"page":"235-238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10\u2009ng\/ml"],"prefix":"10.1038","volume":"9","author":[{"given":"O","family":"Kayg\u0131s\u0131z","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6","family":"U\u011furlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ko\u015fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"\u0130nal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"\u00c7etinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,5,23]]},"reference":[{"key":"BF4500885_CR1","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S0022-5347(17)35304-1","volume":"151","author":"DW Keetch","year":"1994","unstructured":"Keetch DW, Catalona WJ, Smith DS . Serial prostatic biopsies in men with persistently elevated serum PSA values. J Urol 1994; 151: 1571\u20131574.","journal-title":"J Urol"},{"key":"BF4500885_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.eururo.2003.11.024","volume":"45","author":"SY Eski\u00e7orap\u00e7\u0131","year":"2004","unstructured":"Eski\u00e7orap\u00e7\u0131 SY, Baydar DE, Akbal C, Sofikerim M, Gunay M, Ekici S et al. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol 2004; 45: 444\u2013449.","journal-title":"Eur Urol"},{"key":"BF4500885_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1570-9124(03)00003-5","volume":"1","author":"H-P Schmid","year":"2003","unstructured":"Schmid H-P, Prikler L, Sturgeon CM, Semjonow A . Diagnosis of prostate cancer \u2013 the clinical use of prostate specific antigen. EAU Update Ser 2003; 1: 3\u20138.","journal-title":"EAU Update Ser"},{"key":"BF4500885_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/pros.2990200205","volume":"20","author":"DE Neal Jr","year":"1992","unstructured":"Neal Jr DE, Clejan S, Sarma D, Moon TD . Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992; 20: 105\u2013111.","journal-title":"Prostate"},{"key":"BF4500885_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","volume":"154","author":"RB Nadler","year":"1995","unstructured":"Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL . Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154: 407\u2013413.","journal-title":"J Urol"},{"key":"BF4500885_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1159\/000020190","volume":"37","author":"J Morote","year":"2000","unstructured":"Morote J, Lopez M, Encabo G, Torres IM . Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 2000; 37: 537\u2013540.","journal-title":"Eur Urol"},{"key":"BF4500885_CR7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J . Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 1997; 157: 1301\u20131304.","journal-title":"J Urol"},{"key":"BF4500885_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","volume":"167","author":"CB Bozeman","year":"2002","unstructured":"Bozeman CB, Carver BS, Eastham JA, Venable DD . Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 2002; 167: 1723\u20131726.","journal-title":"J Urol"},{"key":"BF4500885_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1159\/000052500","volume":"39","author":"G Karazanashvilii","year":"2001","unstructured":"Karazanashvilii G, Managadze L . Prostate-specific antigen value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4\u201310\u2009ng\/ml and nonsuspicious results of digital rectal examination. Eur Urol 2001; 39: 538\u2013543.","journal-title":"Eur Urol"},{"key":"BF4500885_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0022-5347(05)63959-6","volume":"169","author":"BS Carver","year":"2003","unstructured":"Carver BS, Caleb BB, Williams BJ, Venable DD . The prevalence of men with national institutes of health category IV prostatis and association with serum prostate specific antigen. J Urol 2003; 169: 589\u2013591.","journal-title":"J Urol"},{"key":"BF4500885_CR11","first-page":"3003","volume-title":"Campell's Urology","author":"RE Reiter","year":"2002","unstructured":"Reiter RE, deKernion JB . Epidemilogy, etiology, and prevention of prostate cancer. In: Walsh PC et al. (eds). Campell's Urology, vol. 4. Saunders: Philadelphia, 2002; pp 3003\u20133024."},{"key":"BF4500885_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0090-4295(03)00688-5","volume":"62","author":"C Kwak","year":"2003","unstructured":"Kwak C, Ku JH, Kim T, Park DW, Choi KY, Lee E et al. Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 2003; 62: 854\u2013859.","journal-title":"Urology"},{"key":"BF4500885_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"1999","unstructured":"Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E . Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis. Eur Urol 1999; 37: 404\u2013412.","journal-title":"Eur Urol"},{"key":"BF4500885_CR14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.eururo.2004.08.003","volume":"46","author":"I Stancik","year":"2004","unstructured":"Stancik I, L\u00fcftenegger W, Klimpfinger M, Muller MM, Hoeltl W . Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 2004; 46: 760\u2013764.","journal-title":"Eur Urol"},{"key":"BF4500885_CR15","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0022-5347(01)63570-5","volume":"159","author":"DK Ornste\u0131n","year":"1998","unstructured":"Ornste\u0131n DK, Sm\u0131th DS, Humphrey PA, Catalona WJ . The effect of prostate volume, age, total prostate spec\u0131f\u0131c antigen level and acute inflammation on the percentage of free serum prostate spec\u0131f\u0131c antigen levels \u0131n men without clinically detectable prostate cancer. J Urol 1998; 159: 1234\u20131237.","journal-title":"J Urol"},{"key":"BF4500885_CR16","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1097\/00005392-199805000-00050","volume":"159","author":"K Jung","year":"1998","unstructured":"Jung K, Meyer A, Lein M, Rudolph B, Schnorr D, Loening SA . Rat\u0131o of free-to-total prostate spec\u0131f\u0131c antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998; 159: 1595\u20131598.","journal-title":"J Urol"},{"issue":"Suppl 1","key":"BF4500885_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/BF01716032","volume":"22","author":"B Bergman","year":"1994","unstructured":"Bergman B . On the relevance of Gram-positive bacteria in prostatitis. Infection 1994; 22 (Suppl 1): 22.","journal-title":"Infection"},{"key":"BF4500885_CR18","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/JCM.37.6.1863-1870.1999","volume":"37","author":"MA Tanner","year":"1999","unstructured":"Tanner MA, Shoskes DE, Shahed A, Pace NR . Prevalence of Corynebacterial 16S rRNA sequences in patients with bacterial and \u2018non-bacterial\u2019 prostatitis. J Clin Microbiol 1999; 37: 1863\u20131870.","journal-title":"J Clin Microbiol"},{"key":"BF4500885_CR19","first-page":"603","volume-title":"Campell's Urology","author":"JC Nickel","year":"2002","unstructured":"Nickel JC . Prostatitis and related conditions. In: Walsh PC et al. (eds). Campell's Urology, vol. 1. Saunders: Philadelphia, 2002; pp 603\u2013630."},{"key":"BF4500885_CR20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1464-410X.1993.tb16297.x","volume":"72","author":"JT Isaacs","year":"1993","unstructured":"Isaacs JT . Ureaplasma urealyticum in the urogenital tract of patients with chronic prostatitis or related symptomatology. Br J Urol 1993; 72: 918\u2013921.","journal-title":"Br J Urol"},{"key":"BF4500885_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0090-4295(03)00565-X","volume":"62","author":"W Bundrick","year":"2003","unstructured":"Bundrick W, Heron SP, Ray P, Schiff WM, Tennenberg AM, Wiesinger BA et al. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology 2003; 62: 537\u2013541.","journal-title":"Urology"},{"key":"BF4500885_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1464-410X.1997.00252.x","volume":"80","author":"WP Witjes","year":"1997","unstructured":"Witjes WP, Aarnink RG, Ezz-el-Din K, Wijkstra H, Debruyne EM, de la Rosette JJ . The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms. Br J Urol 1997; 80: 84\u201390.","journal-title":"Br J Urol"},{"key":"BF4500885_CR23","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0022-5347(05)67026-7","volume":"164","author":"JM Potts","year":"2000","unstructured":"Potts JM . Prospective identification of national institutes of health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000; 164: 1550\u20131553.","journal-title":"J Urol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4500885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500885","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:08:18Z","timestamp":1648678098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4500885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,23]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["BF4500885"],"URL":"https:\/\/doi.org\/10.1038\/sj.pcan.4500885","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,23]]},"assertion":[{"value":"29 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}